Detalhe da pesquisa
1.
Comparison of anti-cancer effects of novel protein disulphide isomerase (PDI) inhibitors in breast cancer cells characterized by high and low PDIA17 expression.
Cancer Cell Int
; 22(1): 218, 2022 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35725466
2.
The Antidepressant-like Activity, Effects on Recognition Memory Deficits, Bioavailability, and Safety after Chronic Administration of New Dual-Acting Small Compounds Targeting Neuropsychiatric Symptoms in Dementia.
Int J Mol Sci
; 23(19)2022 Sep 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36232749
3.
Hybrid molecules combining GABA-A and serotonin 5-HT6 receptors activity designed to tackle neuroinflammation associated with depression.
Eur J Med Chem
; 247: 115071, 2023 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36603509
4.
Discovery of new, highly potent and selective inhibitors of BuChE - design, synthesis, in vitro and in vivo evaluation and crystallography studies.
Eur J Med Chem
; 249: 115135, 2023 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36696766
5.
Promising anticonvulsant and/or analgesic compounds among 5-chloro-2- or 5-chloro-4-methyl derivatives of xanthone coupled to aminoalkanol moieties-Design, synthesis and pharmacological evaluation.
Chem Biol Drug Des
; 101(2): 278-325, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35713377
6.
Quantitative measurement of selected protein biomarkers of endothelial dysfunction in plasma by micro-liquid chromatography-tandem mass spectrometry based on stable isotope dilution method.
Talanta
; 194: 1005-1016, 2019 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30609507
7.
Development, validation and application of a micro-liquid chromatography-tandem mass spectrometry based method for simultaneous quantification of selected protein biomarkers of endothelial dysfunction in murine plasma.
J Pharm Biomed Anal
; 149: 465-474, 2018 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29172146
8.
Study on the effect of EMD386088, a 5-HT6 receptor partial agonist, in enhancing the anti-immobility action of some antidepressants in rats.
Naunyn Schmiedebergs Arch Pharmacol
; 391(1): 37-49, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29079874
9.
HBK-17, a 5-HT1A Receptor Ligand With Anxiolytic-Like Activity, Preferentially Activates ß-Arrestin Signaling.
Front Pharmacol
; 9: 1146, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30410441